Faculty profile

Bertrand Lebouché

ResearcherMédecine interneUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Bertrand Lebouché

Researcher

Médecine interne

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adaptive Trials Hiv Implementation Science Stbbi Training Communauté Virtuelle Covid-19 Objets Connectés

Latest papers

Quantifying and Disclosing the Environmental Footprint of AI in Research: Life Cycle-Informed Framework and Open-Access Calculator Development Study.
JMIR AI · 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV.
Gastro hep advances · 2026
A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada.
The International journal on drug policy · 2026

All 12 publications

Latest funding

Building Capacity in Innovative Adaptive Trial Designs for HIV and STBBI Research: The CTN-Québec Training Platform
CIHR · 2025 · Principal investigator
$800,000
Continuum PAROLE-Onco : Vers le développement de compétences en auto-soins pour améliorer l'expérience de la vie après les traitements aigus de cancer du sein.
CIHR · 2023 · Co-investigator
$1,365,525
Évaluation en temps réel du déploiement de technologies connectées et du partenariat de soins et services dans le contexte de crise sanitaire lié à la COVID-19 - le programme Techno-COVID-Partenariat
CIHR · 2020 · Principal investigator
$502,487

All 4 grants and awards

12 publications.

Quantifying and Disclosing the Environmental Footprint of AI in Research: Life Cycle-Informed Framework and Open-Access Calculator Development Study.

Mozafari K, Ma Y, Amoei M, Lebouche B, Osmanlliu E, Poenaru D

JMIR AI2026

DOI: 10.2196/90770 PMID: 42612154

Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV.

Cinque F, Nudo M, Saeed S, Lim J, Kablawi D, Mariano G, Lupu A, Elgretli W, Moodie EEM, Price C, Monteith K, Cooper C, Walmsley S, Kronfli N, Cox J, Costiniuk C, De Pokomandy A, Routy JP, Klein MB, Lebouche B, Sebastiani G

Gastro hep advances2026

DOI: 10.1016/j.gastha.2026.100966 PMID: 42181046

A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada.

Weight C, Mambro A, Dussault C, Chalifoux S, Del Balso L, Petropoulos A, Lim M, Halavrezos A, Lebouche B, Sebastiani G, Klein MB, Cox J, Latimer E, Kronfli N

The International journal on drug policy2026

DOI: 10.1016/j.drugpo.2025.105136 PMID: 41494308

Intersections of vitamin D deficiency, HIV and chronic liver diseases.

Farina F, Datta A, Morin SN, Saeed S, Lebouche B, Guaraldi G, Petta S, Sebastiani G

HIV medicine2026

DOI: 10.1111/hiv.70117 PMID: 40974294

A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study.

Kronfli N, Mambro A, O'Brien A, Dussault C, Chalifoux S, Balso LD, Petropoulos A, Lim M, Halavrezos A, Lebouche B, Sebastiani G, Klein MB, Cox J

The International journal on drug policy2025

DOI: 10.1016/j.drugpo.2025.104873 PMID: 40513132

Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.

Kronfli N, Mambro A, Riback LR, Ortiz-Paredes D, Dussault C, Chalifoux S, Del Balso L, Petropoulos A, Lim M, Halavrezos A, Sebastiani G, Klein MB, Lebouche B, Cox J, Akiyama MJ

The International journal on drug policy2024

DOI: 10.1016/j.drugpo.2024.104624 PMID: 39426103

Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial.

Shengir M, Lebouche B, Elgretli W, Saeed S, Ramanakumar AV, Giannakis A, De Pokomandy A, Cox J, Costiniuk C, Routy JP, Klein MB, Sebastiani G

HIV medicine2024

DOI: 10.1111/hiv.13531 PMID: 37641534

Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.

Benmassaoud A, Macias J, Delamarre A, Corma-Gomez A, Guaraldi G, Milic J, Rockstroh JK, Van Bremen K, Tsochatzis E, Mulay A, Price J, Garvey LJ, Lemoine M, Kablawi D, Lebouche B, Klein MB, Ballesteros LR, Boesecke C, Schepis F, Bhagani S, Cooke G, Berzigotti A, Hirose K, Pineda JA, Ramanakumar AV, De-Ledinghen V, Saeed S, Sebastiani G

Liver international : official journal of the International Association for the Study of the Liver2023

DOI: 10.1111/liv.15605 PMID: 37183550

Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.

Cervo A, Milic J, Mazzola G, Schepis F, Petta S, Krahn T, Lebouche B, Deschenes M, Cascio A, Guaraldi G, Sebastiani G

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

DOI: 10.1093/cid/ciaa430 PMID: 32280969

Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.

Krahn T, Martel M, Sapir-Pichhadze R, Kronfli N, Falutz J, Guaraldi G, Lebouche B, Klein MB, Wong P, Deschenes M, Ghali P, Sebastiani G

The Journal of infectious diseases2020

DOI: 10.1093/infdis/jiaa170 PMID: 32249283

Something wrong or missing on this profile? Suggest a correction

Bertrand Lebouché

Research

Latest papers

Latest funding

Quantifying and Disclosing the Environmental Footprint of AI in Research: Life Cycle-Informed Framework and Open-Access Calculator Development Study.

Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV.

A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada.

Intersections of vitamin D deficiency, HIV and chronic liver diseases.

A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study.

Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.

Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial.

Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.

Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.

Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.

Building Capacity in Innovative Adaptive Trial Designs for HIV and STBBI Research: The CTN-Québec Training Platform

Continuum PAROLE-Onco : Vers le développement de compétences en auto-soins pour améliorer l'expérience de la vie après les traitements aigus de cancer du sein.

Évaluation en temps réel du déploiement de technologies connectées et du partenariat de soins et services dans le contexte de crise sanitaire lié à la COVID-19 - le programme Techno-COVID-Partenariat

What's the secret sauce? Identifying effectiveness principles to enable the design, implementation and transferability of patient and community partnerships amongst marginalized populations using a developmental evaluation approach.

Frequent collaborators

Bertrand Lebouché

Giada Sebastiani

Nadine Kronfli

Sahar Saeed

Cecilia Costiniuk

Amine Benmassaoud

Jean-Pierre Routy

Alexandra de Pokomandy

Jean-Pierre Routy

Cecilia Costiniuk

Esli Osmanlliu

Dan Poenaru

Eric Latimer

Ruth Sapir-Pichhadze

Sharon Walmsley

Curtis Cooper